DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Sean McCarthy is participating in a panel at the Financing Solutions and Strategies for Life Sciences Conference in New York City
News | 10. 19. 2009
